Skip to main navigation
Skip to search
Skip to main content
Rutgers, The State University of New Jersey Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Federal Grants
Research output
Search by expertise, name or affiliation
Stem Cell-based Platform for Targeted Enzyme/Prodrug Therapy of Recurrent Ovarian Cancer
Hatefi, Arash
(PI)
Ernest Mario School of Pharmacy, Pharmaceutics
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Clone Cells
9%
Drug Resistance
11%
Drug Therapy
7%
Enzyme Therapy
100%
Enzymes
6%
Hematology
12%
human CES2 protein
23%
Immunohistochemistry
16%
Irinotecan
14%
Magnetic Resonance Imaging
15%
Mortality
6%
Neoplasm Metastasis
7%
Neoplasms
38%
Neoplastic Stem Cells
12%
Ovarian Epithelial Carcinoma
13%
Ovarian Neoplasms
87%
Ovary
10%
Pharmaceutical Preparations
24%
Platinum
12%
Prodrugs
86%
Recurrence
27%
Standard of Care
23%
Stem Cells
66%
Survival
19%
Survival Rate
27%
Technology
7%
Therapeutics
11%
TP protocol
17%
Tropism
14%
Tumor Burden
11%